New supply notices
Flamazine cream discontinuation
The supplier, Smith & Nephew, will stop supplying Flamazine cream (Pharmacode: 2343851) sulfadiazine silver 1% to the New Zealand market. Stock is expected to run out in December 2026/January 2027.
Glibenclamide (Daonil) tab 5 mg discontinuation
The supplier, Sanofi, is discontinuing Daonil (glibenclamide) tab 5 mg globally. Stock is expected to run out in February 2027.
Updated supply notices |
Mometasone furoate (Elocon) lotion 0.1%
The next shipment of lotion (Pharmacode: 2177633) has been delayed, we don’t have a new date. The other presentations remain available.
Naltrexone tab 50 mg: Brand change
Naltrexone Lupin will be funded from 1 November 2026. It will be the main funded brand. Naltraccord and Naltrexone GH will be delisted from 1 April 2027. Details and pictures are available on the website.
Nutricia: supply issue
The following products are out of stock:
Loprofin animal shapes pasta Pharmacode: 2304317
Fortijuice (Apple flavour) Pharmacode: 2224518
Oestradiol (Estradot) 100 mcg patch
The supplier has filled all wholesalers' backorders with the shipment that arrived in September. A further shipment is expected by mid-October 2026.
We have had reports that some pharmacies have had difficulty ordering other strengths of Estradot patches. We believe this may be localised to some wholesalers in some parts of the country.
The supplier has stock and further shipments are expected.
Sildenafil (Vedafil) 25 and 50 mg tablets
A second 50 mg tablet was funded from 8 October. Dispensings can be claimed thi smonth. Pharmacode: 2738805
Sodium valproate (Epilim) 100 mg crushable tablet Discontinuation
Pharmac has secured additional stock of the Epilim 100 mg crushable tablets. This will ensure supply of this medicine until the end of 2027.
Our initial advice was that stock would run out by November 2026. The additional stock allows more time for people to work with their prescribers to find a suitable alternative.
Teriparatide (Teva)
Teva's UK-branded teriparatide (Pharmacode: 2735768) has now received approval from Medsafe. It can be prescribed and dispensed as normal from now. The S29 label will be removed from the Schedule when it is updated for November 2026.
Tranexamic acid (Mercury Pharma) 500 mg tablets
The shipment of tranexamic acid has arrived and been released to wholesalers. It can still take another 2 or 3 weeks to reach pharmacies around the country.
Consultations & Notifications
Decision to fund medicines for people with high blood pressure and bacterial infections
On 1 November 2026, Pharmac will widen access to the following treatments:
Bedaquiline (Sirturo) – for the treatment of non-tuberculosis mycobacteria (NTM) infection on the Community Schedule and Hospital Medicines List
Linezolid (Zyvox) – for the treatment of NTM infection, on the Community Schedule (already listed on the Hospital Medicines List)
Captopril liquid (DP-Captopril) for the treatment of high blood pressure in patients with autonomic dysreflexia following spinal cord injury on the Community Schedule and Hospital Medicines List
Monthly updates